| Medical and Health Sciences | Lifetime | 700 | SE 14 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 331 | SE 7 | 99.93 |
| Cardiology and Cardiovascular Medicine | Lifetime | 120 | SE 3 | 99.88 |
| Family Practice | Lifetime | 22 | SE 1 | 98.58 |
| Complementary and Alternative Medicine | Lifetime | 274 | SE 7 | 98.64 |
| Psychiatry and Mental health | Lifetime | 818 | SE 28 | 96.52 |
| Radiological and Ultrasound Technology | Lifetime | 412 | SE 8 | 92.32 |
| Geriatrics and Gerontology | Lifetime | 372 | SE 10 | 89.45 |
| Emergency Medicine | Lifetime | 968 | SE 21 | 87.64 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 135 | SE 3 | 99.33 |
| General Health Professions | 2021-2025 | 337 | SE 3 | 97.46 |
| Public, Environmental and Occupational Health | 2021-2025 | 780 | SE 11 | 92.26 |
| Medical Physiology | 2021-2025 | 913 | SE 27 | 84.65 |
| Medication Adherence and Compliance | Lifetime | 5 | SE 1 | 99.74 |
| Cardiac Health and Mental Health | Lifetime | 16 | SE 1 | 99.71 |
| Chronic Disease Management Strategies | Lifetime | 26 | SE 2 | 99.52 |
| Heart Failure Treatment and Management | Lifetime | 41 | SE 2 | 99.83 |
| Nursing care and research | Lifetime | 3 | SE 1 | 99.47 |
| Cardiac pacing and defibrillation studies | Lifetime | 70 | SE 2 | 99.71 |
| Cardiovascular Function and Risk Factors | Lifetime | 270 | SE 5 | 99.47 |
| Family and Patient Care in Intensive Care Units | Lifetime | 77 | SE 1 | 98.96 |
| Diabetes Management and Education | Lifetime | 104 | SE 1 | 98.67 |
| Sexual function and dysfunction studies | Lifetime | 115 | SE 2 | 98.39 |
| Cardiovascular and exercise physiology | Lifetime | 357 | SE 15 | 98.40 |
| Cardiac Arrest and Resuscitation | Lifetime | 997 | SE 24 | 97.63 |
| Mechanical Circulatory Support Devices | Lifetime | 658 | SE 8 | 97.48 |
| Cardiovascular Issues in Pregnancy | Lifetime | 380 | SE 4 | 96.92 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 579 | SE 16 | 96.16 |
| Potassium and Related Disorders | Lifetime | 260 | SE 8 | 95.00 |
| Telemedicine and Telehealth Implementation | Lifetime | 892 | SE 13 | 87.17 |
| GDF15 and Related Biomarkers | Lifetime | 599 | SE 24 | 80.11 |
| Stuttering Research and Treatment | Lifetime | 625 | SE 7 | 79.47 |
| Cardiac Health and Mental Health | 2021-2025 | 30 | SE 2 | 98.06 |
| Heart Failure Treatment and Management | 2021-2025 | 61 | SE 3 | 99.41 |
| Diabetes Management and Education | 2021-2025 | 37 | SE 1 | 97.08 |
| Chronic Disease Management Strategies | 2021-2025 | 117 | SE 6 | 95.93 |
| Nursing care and research | 2021-2025 | 8 | SE 1 | 96.39 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 478 | SE 6 | 94.87 |
| Mobile Health and mHealth Applications | 2021-2025 | 333 | SE 5 | 91.67 |
| Cardiovascular and exercise physiology | 2021-2025 | 474 | SE 9 | 91.46 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 954 | SE 14 | 89.54 |
| Physical Activity and Health | 2021-2025 | 726 | SE 13 | 87.77 |
| Electrolyte and hormonal disorders | 2021-2025 | 371 | SE 14 | 76.69 |
| Medication Adherence and Compliance | 2021-2025 | 672 | SE 14 | 74.43 |
| Technology Use by Older Adults | 2021-2025 | 867 | SE 27 | 61.73 |
